{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T22:22:21Z","timestamp":1755037341545,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T00:00:00Z","timestamp":1591228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100005440","name":"Center for Scientific Review","doi-asserted-by":"publisher","award":["P50 CA174521-01"],"award-info":[{"award-number":["P50 CA174521-01"]}],"id":[{"id":"10.13039\/100005440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1245\/s10434-020-08695-0","type":"journal-article","created":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T22:02:30Z","timestamp":1591308150000},"page":"2583-2585","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["It May Not Be Too Little or Too Late: Resecting Primary Small Bowel Neuroendocrine Tumors in the Presence of Metastatic Disease"],"prefix":"10.1245","volume":"27","author":[{"given":"James R.","family":"Howe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,6,4]]},"reference":[{"key":"8695_CR1","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/SLA.0b013e31818e4641","volume":"249","author":"KY Bilimoria","year":"2009","unstructured":"Bilimoria KY, Bentrem DJ, Wayne JD, Ko CY, Bennett CL, Talamonti MS. Small bowel cancer in the United States: changes in epidemiology, treatment, and survival over the last 20 years. Ann Surg. 2009;249:63\u201371.","journal-title":"Ann Surg."},{"key":"8695_CR2","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3:1335\u201342.","journal-title":"JAMA Oncol."},{"key":"8695_CR3","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","volume":"26","author":"JC Yao","year":"2008","unstructured":"Yao JC, Hassan M, Phan A, et al. One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States. J Clin Oncol. 2008;26:3063\u201372.","journal-title":"J Clin Oncol."},{"key":"8695_CR4","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1245\/s10434-014-3728-0","volume":"21","author":"SK Sherman","year":"2014","unstructured":"Sherman SK, Maxwell JE, O\u2019Dorisio MS, O\u2019Dorisio TM, Howe JR. Pancreastatin predicts survival in neuroendocrine tumors. Ann Surg Oncol. 2014;21:2971\u201380.","journal-title":"Ann Surg Oncol."},{"key":"8695_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.surg.2018.04.070","volume":"165","author":"AT Scott","year":"2019","unstructured":"Scott AT, Breheny PJ, Keck KJ, et al. Effective cytoreduction can be achieved in patients with numerous neuroendocrine tumor liver metastases (NETLMs). Surgery. 2019;165:166\u201375.","journal-title":"Surgery."},{"key":"8695_CR6","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1097\/MPA.0000000000000846","volume":"46","author":"JR Howe","year":"2017","unstructured":"Howe JR, Cardona K, Fraker DL, et al. The surgical management of small bowel neuroendocrine tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society. Pancreas. 2017;46:715\u201331.","journal-title":"Pancreas."},{"key":"8695_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.surg.2015.05.040","volume":"159","author":"JE Maxwell","year":"2016","unstructured":"Maxwell JE, Sherman SK, O\u2019Dorisio TM, Bellizzi AM, Howe JR. Liver-directed surgery of neuroendocrine metastases: what is the optimal strategy? Surgery. 2016;159:320\u201333.","journal-title":"Surgery."},{"key":"8695_CR8","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00268-002-6630-z","volume":"26","author":"P Hellman","year":"2002","unstructured":"Hellman P, Lundstrom T, Ohrvall U, et al. Effect of surgery on the outcome of midgut carcinoid disease with lymph node and liver metastases. World J Surg. 2002;26:991\u20137.","journal-title":"World J Surg."},{"key":"8695_CR9","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1677\/ERC-09-0042","volume":"16","author":"A Ahmed","year":"2009","unstructured":"Ahmed A, Turner G, King B, et al. Midgut neuroendocrine tumours with liver metastases: results of the UKINETS study. Endocr Relat Cancer. 2009;16:885\u201394.","journal-title":"Endocr Relat Cancer."},{"key":"8695_CR10","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.surg.2006.07.033","volume":"140","author":"B Givi","year":"2006","unstructured":"Givi B, Pommier SJ, Thompson AK, Diggs BS, Pommier RF. Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival. Surgery. 2006;140:891\u20137; discussion 897\u20138.","journal-title":"Surgery."},{"key":"8695_CR11","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.surg.2018.09.006","volume":"165","author":"JF Tierney","year":"2019","unstructured":"Tierney JF, Chivukula SV, Wang X, et al. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery. 2019;165:644\u201351.","journal-title":"Surgery."},{"key":"8695_CR12","doi-asserted-by":"publisher","unstructured":"Polcz M, Schlegel C, Edwards GC, et al. Primary tumor resection offers survival benefit in patients with metastatic midgut neuroendocrine tumors. Ann Surg Oncol. 2020. https:\/\/doi.org\/10.1245\/s10434-020-08602-7.","DOI":"10.1245\/s10434-020-08602-7"},{"key":"8695_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1001\/jamaoncol.2017.3326","volume":"4","author":"K Daskalakis","year":"2018","unstructured":"Daskalakis K, Karakatsanis A, Hessman O, et al. Association of a prophylactic surgical approach to stage IV small intestinal neuroendocrine tumors with survival. JAMA Oncol. 2018;4:183\u20139.","journal-title":"JAMA Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-08695-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-08695-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,3]],"date-time":"2021-06-03T23:09:43Z","timestamp":1622761783000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-08695-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":13,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["8695"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-08695-0","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2020,6,4]]},"assertion":[{"value":"21 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}